News and Announcements
Watch the QBiotics Product Overview Video
- Published August 29, 2016 11:20AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
ABOUT QBIOTICS
QBiotics Limited is developing a pipeline of promising drugs in the area of cancer and wound healing. Its lead drug, EBC-46, targets solid tumours and is currently in late pre-clinical development in preparation for a Human Clinical Phase I/II trial with the USA’s FDA. EBC-46 is also in late stage development for the veterinary market through the USA’s FDA-CVM.